Val-Cit

CAS No. 159858-33-0

Val-Cit( —— )

Catalog No. M27024 CAS No. 159858-33-0

Val-Cit is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 215 Get Quote
10MG 312 Get Quote
25MG 530 Get Quote
50MG 758 Get Quote
100MG 1044 Get Quote
500MG 2097 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Val-Cit
  • Note
    Research use only, not for human use.
  • Brief Description
    Val-Cit is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
  • Description
    Val-Cit is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).(In Vitro):ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
  • In Vitro
    ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Antibacterial| GRP78
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    159858-33-0
  • Formula Weight
    274.321
  • Molecular Formula
    C11H22N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 62.5 mg/mL (227.84 mM)
  • SMILES
    CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=O)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Machihara K, et al. Questiomycin A stimulates sorafenib-induced cell death via suppression of glucose-regulated protein 78. Biochem Biophys Res Commun. 2017 Oct 7;492(1):33-40.
molnova catalog
related products
  • Isochlorogenic acid ...

    35-Dicaffeoylquinic acid is a natural phenolic acid with antioxidant and anti-inflammatory activities.

  • O-Succinylhomoserine

    O-Succinylhomoserine is an intermediate in the synthesis of cystathionine by E coli..

  • Fz7-21

    Fz7-21 is a peptide antagonist of FZD7 . It antagonises WNT3A-induced Wnt-β-catenin signalling in HEK293 expressing FZD7. Fz7-21 impairs Wnt/β-catenin signaling in HEK293 cells stimulated with exogenous WNT3A (IC50=100?nM) or transfected with a construct expressing WNT3A or WNT1. Fz7-21 also blocks WNT3A-mediated stabilization of β-catenin in mouse L cells (IC50=50?nM).